Overview
COCH market data
Price History
No market bars yet for COCH. This page will populate once the next provider sweep lands.
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for COCH. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
EXCLUSIVE: Envoy Medical Completes 3-Month Follow-Ups For All 56 Trial Patients, Advancing Its Fully Implanted Acclaim Cochlear Implant Toward FDA submission; 12-Month Visit Milestone Expected By April 2027Benzinga · Jul 21, 2026, 1:00 PM
EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear ImplantBenzinga · Jul 21, 2026, 1:00 PM
HC Wainwright & Co. Reiterates Buy on Envoy Medical, Maintains $2.5 Price TargetBenzinga · Jul 15, 2026, 11:45 AM
Envoy Medical shares are trading higher after the company announced 12‑month Stage 1 data from its Acclaim cochlear implant trial, showing continued improvement in word recognition.Benzinga · Jul 14, 2026, 5:02 PM
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial ResultsBenzinga · Jul 14, 2026, 1:01 PM
EXCLUSIVE: Envoy Medical Says 12-Month Data Shows Continued Improvement in Word Recognition in Ear Implant StudyBenzinga · Jul 14, 2026, 1:01 PM
Envoy Medical Submits First Module Of Modular Premarket Approval Application To FDA For Breakthrough Device-Designated Product; Co Plans Four Module Submissions, Final Data Filing Targeted Q2 2027Benzinga · Jun 30, 2026, 12:50 PM
Envoy Medical Terminates At-The-Market Equity Facility To Offer, Sell $15M Common SharesBenzinga · Jun 25, 2026, 12:45 PM
Envoy Medical Secures Multiple Australia And Europe Patents For Implantable Hearing System Innovations And Battery Recharge Safety TechnologyBenzinga · May 20, 2026, 12:45 PM
Envoy Medical Q1 EPS $(0.08) Beats $(0.14) Estimate, Sales $39.000K Miss $60.000K EstimateBenzinga · May 11, 2026, 12:13 PM